HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
Open Access
- 19 September 2014
- journal article
- review article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (S6) , S13
- https://doi.org/10.1186/1471-2334-14-s6-s13
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Hepatitis C seroconversions in HIV infection across Europe: which regions and patient groups are affected?Liver International, 2015
- Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDAHIV Medicine, 2013
- Stability of hepatitis C virus (HCV) RNA levels among interferon‐naïve HIV/HCV‐coinfected individuals treated with combination antiretroviral therapyHIV Medicine, 2013
- Hepatitis C viral load, genotype 3 and interleukin-28B CC genotype predict mortality in HIV and hepatitis C-coinfected individualsAIDS, 2012
- A Standardized Algorithm for Determining the Underlying Cause of Death in HIV Infection as AIDS or non-AIDS Related: Results from the EuroSIDA StudyHIV Research & Clinical Practice, 2011
- Initial presentation of acute hepatitis C virus (HCV) infection among HIV-negative and HIV-positive individuals-experience from 2 large German networks on the study of acute HCV infection.Clinical Infectious Diseases, 2009
- Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?AIDS, 2005
- Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral TherapyThe Journal of Infectious Diseases, 2005
- Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV-Infected PatientsNew England Journal of Medicine, 2004
- Lack of Association of Hepatitis C Virus Load and Genotype with Risk of End‐Stage Liver Disease in Patients with Human Immunodeficiency Virus CoinfectionThe Journal of Infectious Diseases, 2001